225 related articles for article (PubMed ID: 17644085)
1. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
[TBL] [Abstract][Full Text] [Related]
3. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
[TBL] [Abstract][Full Text] [Related]
4. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
[TBL] [Abstract][Full Text] [Related]
6. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
Obrosova IG; Mabley JG; Zsengellér Z; Charniauskaya T; Abatan OI; Groves JT; Szabó C
FASEB J; 2005 Mar; 19(3):401-3. PubMed ID: 15611153
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
Vareniuk I; Pavlov IA; Obrosova IG
Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
[TBL] [Abstract][Full Text] [Related]
8. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
[TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.
Stavniichuk R; Shevalye H; Lupachyk S; Obrosov A; Groves JT; Obrosova IG; Yorek MA
Diabetes Metab Res Rev; 2014 Nov; 30(8):669-78. PubMed ID: 24687457
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.
Arora M; Kumar A; Kaundal RK; Sharma SS
Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138
[TBL] [Abstract][Full Text] [Related]
11. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.
Stavniichuk R; Drel VR; Shevalye H; Maksimchyk Y; Kuchmerovska TM; Nadler JL; Obrosova IG
Exp Neurol; 2011 Jul; 230(1):106-13. PubMed ID: 21515260
[TBL] [Abstract][Full Text] [Related]
12. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
13. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst.
Szabó C; Mabley JG; Moeller SM; Shimanovich R; Pacher P; Virag L; Soriano FG; Van Duzer JH; Williams W; Salzman AL; Groves JT
Mol Med; 2002 Oct; 8(10):571-80. PubMed ID: 12477967
[TBL] [Abstract][Full Text] [Related]
14. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
[TBL] [Abstract][Full Text] [Related]
15. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Negi G; Kumar A; Sharma SS
Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
[TBL] [Abstract][Full Text] [Related]
16. Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats.
Lupachyk S; Watcho P; Shevalye H; Vareniuk I; Obrosov A; Obrosova IG; Yorek MA
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E396-404. PubMed ID: 23736542
[TBL] [Abstract][Full Text] [Related]
17. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
[TBL] [Abstract][Full Text] [Related]
18. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats.
Sugimoto K; Rashid IB; Shoji M; Suda T; Yasujima M
J Pain; 2008 Mar; 9(3):237-45. PubMed ID: 18331706
[TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
